Investment Considerations Lexaria Bioscience Corp. has disruptive proprietary technology protected by a broad international patent portfolio. The company has been issued 37 patents in the U.S., European Union and other countries, with many more pending around the world. Lexaria’s DehydraTECH technology has a vast worldwide, multi-billion-dollar total addressable market, including multiple rapid-growth segments like cannabinoid … Continue reading “Lexaria Bioscience Corp. (NASDAQ: LEXX)”
New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.
Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.
Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.